Investigational Site Number : 2500008

Angers 49933

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer Metastatic, Glycogen Storage Disease Type II;Pompe's Disease

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed